Recombinant baculovirus as a highly potent vector for gene therapy of human colorectal carcinoma: Molecular cloning, expression, and in vitro characterization

Molecular Biotechnology

Volumn 45, Issue 2, 2010, Pages 129-139

  Paul, Arghya ^a   Jardin, Barbara A ^a   Kulamarva, Arun ^a   Malhotra, Meenakshi ^a   Elias, Cynthia B ^b,c   Prakash, Satya ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b Sanofi Pasteur   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

BacMam; Baculovirus; Biosafety; Colorectal cancer; Gene therapy; Therapeutic deliverys; Transduction

Indexed keywords

ANIMAL VIRUS; AUTOGRAPHA CALIFORNICA; BACULOVIRUS; CANCER GENE THERAPY; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL CANCER CELL; COLORECTAL CARCINOMA; COMBINED EFFECT; FACTORIAL DESIGN; GENE DELIVERY; GENE DELIVERY SYSTEMS; IN-VITRO; INCUBATION TIME; INSECT CELLS; MOLECULAR CLONING; MULTIPLICITY OF INFECTIONS; RECOMBINANT BACULOVIRUS; SAFETY CONCERNS; THERAPEUTIC STRATEGY; TRANSDUCTION EFFICIENCY; VIROTHERAPY;

BACTERIOPHAGES; CLONING; ENZYME INHIBITION; GENE EXPRESSION; GENE TRANSFER; MAMMALS;

GENE THERAPY;

ANTINEOPLASTIC AGENT; BACULOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; VIROTHERAPY AGENT; VIRUS DNA;

ANIMAL CELL; ARTICLE; AUTOGRAPHA CALIFORNICA; BACULOVIRUS; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL STRAIN; CELL STRAIN HEPG2; CELL STRAIN HL 60; CELL STRAIN NEURO 2A; CELL STRAIN PANC 1; CELL STRAIN SKBR 3; CELL STRAIN SW 480; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG SAFETY; EPIGENETICS; FACTORIAL DESIGN; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; INSECT CELL CULTURE; MOLECULAR CLONING; NONHUMAN; POLYHEDROSIS VIRUS; PROCESS OPTIMIZATION; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; VIROTHERAPY; VIRUS CHARACTERIZATION; VIRUS INFECTION; VIRUS RECOMBINANT;

ANALYSIS OF VARIANCE; ANIMALS; BACULOVIRIDAE; CELL LINE, TUMOR; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; ONCOLYTIC VIROTHERAPY; SPODOPTERA; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION;

ANIMALIA; AUTOGRAPHA CALIFORNICA MNPV; AUTOGRAPHA CALIFORNICA NUCLEOPOLYHEDROVIRUS; HEXAPODA; MAMMALIA;

EID: 77954951816     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-010-9248-7     Document Type: Article

References (52)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y. P., Xu, J. Q., Murray, T., et al. (2008). Cancer statistics, 2008. Ca-A Cancer Journal for Clinicians, 58, 71-96.
2. Midgley, R., & Kerr, D. (1999). Colorectal cancer. Lancet, 353, 391-399.
3. Birkenkamp-Demtroder, K., Christensen, L. L., Olesen, S. H., Frederiksen, C. M., Laiho, P., Aaltonen, L. A., et al. (2002). Gene expression in colorectal cancer. Cancer Research, 62, 4352-4363.
4. Palmer, D. H., Chen, M. J., & Kerr, D. J. (2002). Gene therapy for colorectal cancer. British Medical Bulletin, 64, 201-225.
5. Yamamoto, T. Y., Okuda, J. O., Toyoda, M. T., & Tanigawa, N. T. (2002). Gene therapy for colon cancer using survivin antisense expressing replication-incompetent adenoviral vectors. International Journal of Cancer, (Suppl 13), 125.
6. Hemminki, A. (2002). From molecular changes to customised therapy. European Journal of Cancer, 38, 333-338.
7. Kanerva, A., & Hemminki, A. (2004). Modified adenoviruses for cancer gene therapy. International Journal of Cancer, 110, 475-480. (Pubitemid 38658011)
8. Chung-Faye, G. A., Chen, M. J., Green, N. K., Burton, A., Anderson, D., Mautner, V., et al. (2001). In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase. Gene Therapy, 8, 1547-1554.
9. Bazan-Peregrino, M., Sainson, R., Carlisle, R., Waters, R., Harris, A. L., Hernandez-Alcoceba, R., et al. (2008). Virotherapy expressing regulatory angiogenic gene therapy in treatment of breast cancer. Human Gene Therapy, 19, 415.
10. Cafferata, E. G., Maccio, D. R., Lopez, M. V., Viale, D. L., Carbone, C., Mazzolini, G., et al. (2009). A novel A33 promoterbased conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models. Clinical Cancer Research, 15, 3037-3049.
11. Huang, Q., Ji, X., Zhang, J., Cheng, L., Wei, F., Li, H., et al. (2009). Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model. Experimental Eye Research, 89, 193-199.
12. Rognoni, E., Widmaier, M., Haczek, C., Mantwill, K., Holzmuller, R., Gansbacher, B., et al. (2009). Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo. Cancer Gene Therapy, 16, 753-763.
13. Wang, G., Li, G., Liu, H., Yang, C., Yang, X., Jin, J., et al. (2009). E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies. Journal of Gene Medicine, 11, 477-485.
14. Ying, B., Toth, K., Spencer, J. F., Meyer, J., Tollefson, A. E., Patra, D., et al. (2009). INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. Cancer Gene Therapy, 16, 625-637.
15. Koyama, F., Sawada, H., Hirao, T., Fujii, H., Hamada, H., & Nakano, H. (2000). Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of Escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine. Cancer Gene Therapy, 7, 1015-1022. (Pubitemid 30483481)
16. Hofmann, C., Sandig, V., Jennings, G., Rudolph, M., Schlag, P., & Strauss, M. (1995). Efficient gene-transfer into human hepatocytes by baculovirus vectors. Proceedings of the National Academy of Sciences of the United States of America, 92, 10099-10103.
17. Stanbridge, L. J., Dussupt, V., & Maitland, N. J. (2003). Baculoviruses as Vectors for Gene Therapy against Human Prostate Cancer. Journal of Biomedicine and Biotechnology, 2003, 79-91.
18. Nesbit, M., Fu, Z. F., Mcdonaldsmith, J., Steplewski, Z., & Curtis, P. J. (1992). Production of a functional monoclonal-antibody recognizing human colorectal-carcinoma cells from a baculovirus expression system. Journal of Immunological Methods, 151, 201-208.
19. Ozawa, S., Lu, W. X., Bucana, C. D., Kanayama, H. O., Shinohara, H., Fidler, I. J., et al. (2003). Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-beta. International Journal of Oncology, 22, 977-984.
20. Song, S. U., & Boyce, F. M. (2001). Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin). Experimental and Molecular Medicine, 33, 46-53.
21. Huang, W., Tian, X. L., Wu, Y. L., Zhong, J., Yu, L. F., Hu, S. P., et al. (2008). Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene. World Journal of Gastroenterology, 14, 5810-5815.
22. Mirzaei, M., Xu, Y., Elias, C. B., & Prakash, S. (2009). Nonviral production of human interleukin-7 in spodoptera frugiperda insect cells as a soluble recombinant protein. Journal of Biomedicine and Biotechnology, 2009, 8 pp. doi:10.1155/2009/ 637942.
23. Jardin, B. A., Montes, J., Lanthier, S., Tran, R., & Elias, C. (2007). High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system. Biotechnology and Bioengineering, 97, 332-345.
24. Jardin, B. A., Zhao, Y., Selvaraj, M., Montes, J., Tran, R., Prakash, S., et al. (2008). Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system. Journal of Biotechnology, 135, 272-280.
25. Bilello, J. P., Delaney, W. E., Boyce, F. M., & Isom, H. C. (2001). Transient disruption of intercellular junctions enables baculovirus entry into nondividing hepatocytes. Journal of Virology, 75, 9857-9871.
26. Boyce, F. M., & Bucher, N. L. R. (1996). Baculovirus-mediated gene transfer into mammalian cells. Proceedings of the National Academy of Sciences of the United States of America, 93, 2348-2352.
27. Wang, C. Y., & Wang, S. (2005). Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculoviral vectors in rat brain. Human Gene Therapy, 16, 1219-1226.
28. Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001). Histone deacetylases and cancer: causes and therapies. Nature Reviews Cancer, 1, 194-202.
29. Rein, D. T., Breidenbach, M., & Curiel, D. T. (2006). Current developments in adenovirus-based cancer gene therapy. Future Oncology, 2, 137-143.
30. Makela, A. R., Matilainen, H., White, D. J., Ruoslahti, E., & Oker-Blom, C. (2006). Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides. Journal of Virology, 80, 6603-6611.
31. Kronschnabl, M., Marschall, M., & Stamminger, T. (2002). Efficient and tightly regulated expression systems for the human cytomegalovirus major transactivator protein IE2p86 in permissive cells. Virus Research, 83, 89-102.
32. Ma, L., Tamarina, N., Wang, Y., Kuznetsov, A., Patel, N., Kending, C., et al. (2000). Baculovirus-mediated gene transfer into pancreatic islet cells. Diabetes, 49, 1986-1991.
33. Zeng, J., Du, J., Zhao, Y., Palanisamy, N., & Wang, S. (2007). Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells, 25, 1055-1061.
34. Chuang, C. K., Wong, T. H., Hwang, S. M., Chang, Y. H., Chen, G. Y., Chiu, Y. C., et al. (2009). Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Molecular Therapy, 17, 889-896.
35. Grassi, G., Kohn, H., Dapas, B., Farra, R., Platz, J., Engel, S., et al. (2006). Comparison between recombinant baculo- and adenoviral-vectors as transfer system in cardiovascular cells. Archives of Virology, 151, 255-271.
36. Nakamichi, K., Matsumoto, Y., Tohya, Y., & Otsuka, H. (2002). Induction of apoptosis in rabbit kidney cell under high-level expression of bovine herpesvirus 1 U(s) ORF8 product. Intervirology, 45, 85-93.
37. Cheng, T., Xu, C. Y., Wang, Y. B., Chen, M., Wu, T., Zhang, J., et al. (2004). A rapid and efficient method to express target genes in mammalian cells by baculovirus. World Journal of Gastroenterology, 10, 1612-1618.
38. Ping, W., Ge, J., Li, S., Zhou, H., Wang, K., Feng, Y., et al. (2006). Baculovirus-mediated gene expression in chicken primary cells. Avian Diseases, 50, 59-63.
39. Leisy, D. J., Lewis, T. D., Leong, J. A., & Rohrmann, G. F. (2003). Transduction of cultured fish cells with recombinant baculoviruses. Journal of General Virology, 84, 1173-1178.
40. Senior, K. (2000). Gene therapy: a rocky start to the new millennium. Molecular Medicine Today, 6, 93.
41. Huser, A., Rudolph, M., & Hofmann, C. (2001). Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nature Biotechnology, 19, 451-455.
42. Hofmann, C., & Strauss, M. (1998). Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Therapy, 5, 531-536.
43. Clay, W. C., Condreay, J. P., Moore, L. B., Weaver, S. L., Watson, M. A., Kost, T. A., et al. (2003). Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells. Assay Drug Development Technologies, 1, 801-810.
44. Song, J., Liang, C.-y., & Chen, X.-w. (2007). Baculovirus-mediated expression of p35 confers resistance to apoptosis in human embryo kidney 293 cells. Virologica Sinica, 22, 389-396.
45. Bossuyt, W., Kazanjian, A., De Geest, N., Van Kelst, S., De Hertogh, G., Geboes, K., et al. (2009). Atonal homolog 1 is a tumor suppressor gene. Plos Biology, 7, 311-326.
46. Kerr, D. (2003). Clinical development of gene therapy for colorectal cancer. Nature Reviews Cancer, 3, 615-622.
47. Obermiller, P. S., Tait, D. L., & Holt, J. T. (2000). Gene therapy for carcinoma of the breast: therapeutic genetic correction strategies. Breast Cancer Research, 2, 28-31.
48. Liu, F. (2001). SMAD4/DPC4 and pancreatic cancer survival- Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clinical Cancer Research, 7: 4115-4121, 2001.
49. Clinical Cancer Research, 7, 3853-3856.
50. Vollmer, C. M., Ribas, A., Butterfield, L. H., Dissette, V. B., Andrews, K. J., Eilber, F. C., et al. (1999). p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. Cancer Research, 59, 4369-4374.
51. Zeng, Y., Jiang, J., Huebener, N., Wenkel, J., Gaedicke, G., Xiang, R., et al. (2005). Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2. Cancer Letters, 228, 187-193.
52. Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Lovino, F., et al. (2007). Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell, 1, 389-402.